This compound is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of various drugs. Its structure, featuring both a carbamoyl group and a carboxylic acid, makes it a valuable intermediate in the production of active pharmaceutical ingredients (APIs), particularly those targeting neurological and cardiovascular diseases. It is often employed in the development of enantiomerically pure compounds, enhancing the efficacy and reducing the side effects of the resulting medications. Additionally, it finds use in research settings for studying enzyme inhibition and as a precursor in peptide synthesis, contributing to advancements in medicinal chemistry and drug discovery.